Intrinsic Value of S&P & Nasdaq Contact Us

HeartBeam, Inc. BEAT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
49/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+316.7%

HeartBeam, Inc. (BEAT) is a publicly traded company in the Healthcare sector, operating within the Medical - Healthcare Information Services industry. The company is headquartered in Santa Clara, CA, United States. The current CEO is Robert Eno.

BEAT has IPO date of 2021-11-11, 21 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $41.33M.

About HeartBeam, Inc.

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

📍 2118 Walsh Avenue, Santa Clara, CA 95050 📞 408 899 4443
Company Details
SectorHealthcare
IndustryMedical - Healthcare Information Services
CountryUnited States
ExchangeNASDAQ Capital Marke
CurrencyUSD
IPO Date2021-11-11
CEORobert Eno
Employees21
Trading Info
Current Price$1.20
Market Cap$41.33M
52-Week Range0.54-4
Beta-0.64
ETFNo
ADRNo
CUSIP42238H108
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message